These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 33315900)
1. Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs. Shioi R; Karaki F; Yoshioka H; Noguchi-Yachide T; Ishikawa M; Dodo K; Hashimoto Y; Sodeoka M; Ohgane K PLoS One; 2020; 15(12):e0243746. PubMed ID: 33315900 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein. Ohgane K; Karaki F; Noguchi-Yachide T; Dodo K; Hashimoto Y Bioorg Med Chem Lett; 2014 Aug; 24(15):3480-5. PubMed ID: 24928400 [TBL] [Abstract][Full Text] [Related]
3. Discovery of oxysterol-derived pharmacological chaperones for NPC1: implication for the existence of second sterol-binding site. Ohgane K; Karaki F; Dodo K; Hashimoto Y Chem Biol; 2013 Mar; 20(3):391-402. PubMed ID: 23521797 [TBL] [Abstract][Full Text] [Related]
4. Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein. Fukuda H; Karaki F; Dodo K; Noguchi-Yachide T; Ishikawa M; Hashimoto Y; Ohgane K Bioorg Med Chem Lett; 2017 Jun; 27(12):2781-2787. PubMed ID: 28465104 [TBL] [Abstract][Full Text] [Related]
5. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems. Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ Cells; 2022 Jan; 11(3):. PubMed ID: 35159129 [TBL] [Abstract][Full Text] [Related]
6. High-content screen for modifiers of Niemann-Pick type C disease in patient cells. Pugach EK; Feltes M; Kaufman RJ; Ory DS; Bang AG Hum Mol Genet; 2018 Jun; 27(12):2101-2112. PubMed ID: 29659804 [TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. Gelsthorpe ME; Baumann N; Millard E; Gale SE; Langmade SJ; Schaffer JE; Ory DS J Biol Chem; 2008 Mar; 283(13):8229-36. PubMed ID: 18216017 [TBL] [Abstract][Full Text] [Related]
8. Endogenous Protein-Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex. Javanshad R; Nguyen TTA; Azaria RD; Li W; Edmison D; Gong LW; Gowrishankar S; Lieberman AP; Schultz ML; Cologna SM J Proteome Res; 2024 Aug; 23(8):3174-3187. PubMed ID: 38686625 [TBL] [Abstract][Full Text] [Related]
9. Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease. Schultz ML; Schache KJ; Azaria RD; Kuiper EQ; Erwood S; Ivakine EA; Farhat NY; Porter FD; Pathmasiri KC; Cologna SM; Uhler MD; Lieberman AP JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36301667 [TBL] [Abstract][Full Text] [Related]
10. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele. Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327 [TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis. Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482 [TBL] [Abstract][Full Text] [Related]
12. Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid. Subramanian K; Hutt DM; Scott SM; Gupta V; Mao S; Balch WE J Biol Chem; 2020 Jun; 295(23):8017-8035. PubMed ID: 32354745 [TBL] [Abstract][Full Text] [Related]
16. Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system. Wang C; Scott SM; Sun S; Zhao P; Hutt DM; Shao H; Gestwicki JE; Balch WE Hum Mol Genet; 2020 Jan; 29(1):1-19. PubMed ID: 31509197 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. Wheeler S; Bhardwaj M; Kenyon V; Ferraz MJ; Aerts JMFG; Sillence DJ FEBS Lett; 2024 Feb; 598(4):477-484. PubMed ID: 38302739 [TBL] [Abstract][Full Text] [Related]
18. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability. Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338 [TBL] [Abstract][Full Text] [Related]
19. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069 [TBL] [Abstract][Full Text] [Related]
20. Different Niemann-Pick C1 Genotypes Generate Protein Phenotypes that Vary in their Intracellular Processing, Trafficking and Localization. Shammas H; Kuech EM; Rizk S; Das AM; Naim HY Sci Rep; 2019 Mar; 9(1):5292. PubMed ID: 30923329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]